FTI insider filing: 50,000 common shares to be sold on NYSE

Rhea-AI Filing Summary

TechnipFMC plc (FTI) filed a Form 144 notifying the proposed sale of 50,000 common shares through Fidelity Brokerage Services with an aggregate market value of $1,932,000. The shares represent vested restricted stock acquired from the issuer on 02/20/2025 (1,876 shares), 02/21/2025 (2,386 shares), 03/08/2025 (15,938 shares), and 05/01/2025 (29,800 shares), which together total 50,000 shares. The filing states the sale is expected on or about 09/22/2025 on the NYSE and lists total outstanding shares of 411,016,473. The filer attests they are not aware of undisclosed material adverse information and includes the standard Rule 144 and Rule 10b5-1 notices.

Insights

Securities Analyst

TL;DR: Small executive/insider sale of vested restricted stock; size appears immaterial to market capitalization.

The notice covers a planned sale of 50,000 common shares valued at approximately $1.93 million, representing about 0.012% of the 411 million shares outstanding. The securities were acquired via recent restricted stock vesting across four dates in 2025 and are to be sold through Fidelity on the NYSE. From a market-impact perspective, the size and nature (post-vesting insider sale) suggest limited price pressure and no immediate signal of company distress based solely on this filing.

Corporate Governance Expert

TL;DR: Routine disclosure of insider selling under Rule 144; procedural attestations included.

The Form 144 contains the required attestations that the seller does not possess undisclosed material information and notes potential reliance on Rule 10b5-1 procedures if applicable. The filing documents compensation-related vesting as the acquisition source, which aligns with routine equity compensation monetization. There is no disclosure here of extraordinary governance events or changes in control.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	50000	1932000.00	411016473	09/22/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/20/2025	Restricted Stock Vesting	Issuer			1876	02/20/2025	Compensation
Common	02/21/2025	Restricted Stock Vesting	Issuer			2386	02/21/2025	Compensation
Common	03/08/2025	Restricted Stock Vesting	Issuer			15938	03/08/2025	Compensation
Common	05/01/2025	Restricted Stock Vesting	Issuer			29800	05/01/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares is TechnipFMC (FTI) proposing to sell in this Form 144?

The filer proposes to sell 50,000 common shares via Fidelity Brokerage Services with an aggregate market value of $1,932,000.

When is the approximate planned sale date for the shares in the Form 144?

The filing lists the approximate date of sale as 09/22/2025 on the NYSE.

How were the securities acquired that are being sold under this Form 144?

All securities were acquired by restricted stock vesting from the issuer on 02/20/2025, 02/21/2025, 03/08/2025, and 05/01/2025.

How large is the sale relative to shares outstanding for FTI?

The sale is 50,000 shares versus 411,016,473 shares outstanding (approximately 0.012% of outstanding shares).

Does the Form 144 state whether the filer knows of any undisclosed material information?

Yes; the filer represents by signing the notice that they do not know any material adverse information about the issuer that has not been publicly disclosed.